Table 1.
Baseline characteristics of study subjects in the entire group and by ethnicity
| Entire Group (N=3509) | Black (N=1814) | White (N=1031) | Hispanic (N=589) | P-Value for ethnicity | |
|---|---|---|---|---|---|
| Age, years (SD) | 43.7 (10.1) | 44.5 (10.2) | 44.7 (10.0) | 40.1 (9.1) | <0.001 |
| Male, N (%) | 1546 (44.1) | 765 (49.5) | 493 (47.8) | 244 (41.4) | 0.001 |
| BMI (SD) | 30.5 (7.6) | 31.6 (8.2) | 29.0 (6.7) | 30.4 (6.6) | <0.001 |
| HTN, N (%) | 1177 (34.4)* | 679 (38.2) | 287 (29.0) | 180 (32.6) | <0.001 |
| Diabetes, N (%) | 408 (11.6) | 258 (14.2) | 70 (6.8) | 72 (12.2) | <0.001 |
| Current smoking, N (%) | 1026 (29.3) | 605 (33.4) | 288 (28.0) | 120 (20.4) | <0.001 |
| Laboratory variables | |||||
| Total Cholesterol, mg/dl | 180.3 (39.6) | 177.7 (40.1) | 183.6 (38.4) | 181.9 (40.1) | 0.001 |
| LDL-C, mg/dl | 106.3 (35.4) | 104.8 (36.6) | 108.3 (34.4) | 107.0 (33.4) | 0.071 |
| HDL-C, mg/dl | 59.8 (14.8) | 52.2 (15.3) | 48.2 (15.0) | 45.7 (11.2) | <0.001 |
| VLDL-C, mg/dl | 24.2 (18.8) | 20.8 (17.7) | 27.1 (18.0) | 29.3 (21.5) | <0.001 |
| Triglycerides, mg/dl | 96 (67–147) | 85 (62–123) | 110 (75–167) | 118 (81–175) | <0.001 |
| IgG MDA-LDL, RLU | 5280 (3522–7969) | 6010 (4204–8857) | 4179 (2952–6435) | 4689 (3094–7247) | <0.001 |
| IgM MDA-LDL, RLU | 15355 (10943–21243) | 15427 (10738–21119) | 15349 (11051–21418) | 15357 (11422–21328) | 0.64 |
| IgG ApoB-IC, RLU | 4179 (3243–5304) | 4272 (3281–5382) | 4023 3158–5073) | 4064 (3246–5252) | <0.001 |
| IgM ApoB-IC, RLU | 3391 (2233–4944) | 3285 (2172–4971) | 3227 (2108–4534( | 4056 (2768–5700) | <0.001 |
75 Individuals either did not have ethnicity identified or identified as “other” and were not included in the ethnicity analysis.
*
In the database, of the 3509 individuals, 3419 had an entry for prevalent hypertension.